IRVINE, Calif.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) reported a net loss applicable to common stock of $2,778,000, or $0.06 per share for the quarter ended June 30, 2009 compared with a net loss applicable to common stock of $3,947,000, or $0.08 per share for the corresponding prior year period. Non-cash stock-based compensation charges for the quarters ended June 30, 2009 and 2008 totaled approximately $103,000 and $339,000, respectively.
